Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Mar Drugs
2019 Oct 31;1711:. doi: 10.3390/md17110622.
Show Gene links
Show Anatomy links
Echinochrome A Reduces Colitis in Mice and Induces In Vitro Generation of Regulatory Immune Cells.
Oh SJ
,
Seo Y
,
Ahn JS
,
Shin YY
,
Yang JW
,
Kim HK
,
Han J
,
Mishchenko NP
,
Fedoreyev SA
,
Stonik VA
,
Kim HS
.
???displayArticle.abstract???
Echinochrome A (Ech A), a natural pigment extracted from sea urchins, is the active ingredient of a marine-derived pharmaceutical called ''histochrome''. Since it exhibits several biological activities including anti-oxidative and anti-inflammatory effects, it has been applied to the management of cardiac injury and ocular degenerative disorders in Russia and its protective role has been studied for other pathologic conditions. In the present study, we sought to investigate the therapeutic potential of Ech A for inflammatory bowel disease (IBD) using a murine model of experimental colitis. We found that intravenous injection of Ech A significantly prevented body weight loss and subsequent lethality in colitis-induced mice. Interestingly, T cell proliferation was significantly inhibited upon Ech A treatment in vitro. During the helper T (Th) cell differentiation process, Ech A stimulated the generation regulatory T (Treg) cells that modulate the inflammatory response and immune homeostasis. Moreover, Ech A treatment suppressed the in vitro activation of pro-inflammatory M1 type macrophages, while inducing the production of M2 type macrophages that promote the resolution of inflammation and initiate tissue repair. Based on these results, we suggest that Ech A could provide a beneficial impact on IBD by correcting the imbalance in the intestinal immune system.
Figure 1. Echinochrome A (Ech A) administration provided therapeutic effects on DSS-induced colitis mice in a dose-dependent manner. (A) Body weight and survival rate monitoring results are shown. The body weight at day 0 considered was as 100%. Numbers in parentheses represent the percentage of dead mice. (B) Disease activity index score for colitis severity at day 12 was significantly reduced in the E10 group. (C) Colon length measurement results showing the protective role of Ech A against DSS-induced colonic damage. (D) The histopathological score of the colitis-affected and normal colon was evaluated with H&E stained tissue section. In total, six animals per group were used. Results are shown as mean ± SD. In (B) and (C), p-value significance was calculated by comparing other groups against the (+) group (marked as +). * P < 0.05, ** P < 0.01, *** P < 0.001.
Figure 2. Ech A impact on mixed lymphocyte reaction (MLR) in vitro. CFSE-labeled human mononuclear cells (MNCs) were cultured for five days in the presence of mitogen or antibodies for CD3/28 with or without Ech A treatment, then the percentage of proliferated cells was evaluated using flow cytometry. The proliferation of both MNCs (A,B) and T cells (C,D) was reduced by Ech A treatment in a dose-dependent manner. VC, vehicle-treated control. ** P < 0.01. Results are shown as mean ± SD.
Figure 3. Ech A impact on Th cell polarization in vitro. (A,B) the percentages of IFN-γ + and IL-4+ cells among CD4+ Th cells were evaluated using flow cytometry to determine the induction ratio of Th1 and Th2 cells, respectively. No significant change was observed upon Ech A treatment. (C) Spontaneous generation of Foxp3+ Treg cells among CD4+ Th cells upon vehicle and Ech A treatment was assessed using flow cytometry. Ech A treatment led to an increase in Treg population compared to the vehicle-treated group. VC, vehicle-treated control. * P < 0.05, ** P < 0.001. Results are shown as mean ± SD.
Figure 4. Ech A impact on M1/M2 macrophage polarization in vitro. (A) After five days of M1 induction, TNF-α concentration in the culture supernatant was measured by ELISA to estimate the M1 polarization efficiency. It is noted that Ech A prevented M1 polarization in vitro in a dose-dependent manner. (B) The IL-10 secretion level was determined using ELISA to evaluate the spontaneous M2 induction efficiency. Ech A treated macrophages were differentiated into M2 macrophages more effectively compared to vehicle-treated cells; (â), no induction control; (+), polarization induced control. The p-value significance was calculated by comparing other groups against the (+) and (â) groups (marked as +) in A and B, respectively. * P < 0.05, ** P < 0.01, *** P < 0.001. Results are shown as mean ± SD.
Abron,
Genistein induces macrophage polarization and systemic cytokine to ameliorate experimental colitis.
2018, Pubmed
Abron,
Genistein induces macrophage polarization and systemic cytokine to ameliorate experimental colitis.
2018,
Pubmed
Baumgart,
Inflammatory bowel disease: cause and immunobiology.
2007,
Pubmed
Berns,
Anti-TNF-α therapies for the treatment of Crohn's disease: the past, present and future.
2016,
Pubmed
Brezar,
PKC-Theta in Regulatory and Effector T-cell Functions.
2015,
Pubmed
Buĭmov,
[Effect of the bioantioxidant histochrome on myocardial injury in reperfusion therapy on patients with myocardial infarction].
2002,
Pubmed
Chen,
Cytokine Networks and T-Cell Subsets in Inflammatory Bowel Diseases.
2016,
Pubmed
Egorov,
[Histochrome, a new antioxidant, in the treatment of ocular diseases].
1999,
Pubmed
Fedoreyev,
Antiviral and Antioxidant Properties of Echinochrome A.
2018,
Pubmed
,
Echinobase
Genot,
Analysis of the role of protein kinase C-alpha, -epsilon, and -zeta in T cell activation.
1995,
Pubmed
Imam,
Effector T Helper Cell Subsets in Inflammatory Bowel Diseases.
2018,
Pubmed
Jeong,
Echinochrome A protects mitochondrial function in cardiomyocytes against cardiotoxic drugs.
2014,
Pubmed
,
Echinobase
Kim,
Human umbilical cord blood mesenchymal stem cells reduce colitis in mice by activating NOD2 signaling to COX2.
2013,
Pubmed
Kim,
A Novel Atypical PKC-Iota Inhibitor, Echinochrome A, Enhances Cardiomyocyte Differentiation from Mouse Embryonic Stem Cells.
2018,
Pubmed
,
Echinobase
Lebedev,
Echinochrome, a naturally occurring iron chelator and free radical scavenger in artificial and natural membrane systems.
2005,
Pubmed
Lebedev,
Iron chelators and free radical scavengers in naturally occurring polyhydroxylated 1,4-naphthoquinones.
2008,
Pubmed
Lennikov,
Amelioration of endotoxin-induced uveitis treated with the sea urchin pigment echinochrome in rats.
2014,
Pubmed
,
Echinobase
Murray,
Protective and pathogenic functions of macrophage subsets.
2011,
Pubmed
Neurath,
Current and emerging therapeutic targets for IBD.
2017,
Pubmed
Park,
Echinochrome A Promotes Ex Vivo Expansion of Peripheral Blood-Derived CD34+ Cells, Potentially through Downregulation of ROS Production and Activation of the Src-Lyn-p110δ Pathway.
2019,
Pubmed
Park,
Therapeutic Cell Protective Role of Histochrome under Oxidative Stress in Human Cardiac Progenitor Cells.
2019,
Pubmed
,
Echinobase
Sayed,
Echinochrome pigment as novel therapeutic agent against experimentally - induced gastric ulcer in rats.
2018,
Pubmed
,
Echinobase
Shapouri-Moghaddam,
Macrophage plasticity, polarization, and function in health and disease.
2018,
Pubmed
Song,
TSG-6 Secreted by Human Adipose Tissue-derived Mesenchymal Stem Cells Ameliorates DSS-induced colitis by Inducing M2 Macrophage Polarization in Mice.
2017,
Pubmed
Tsai,
Galectin-3 suppresses mucosal inflammation and reduces disease severity in experimental colitis.
2016,
Pubmed
Wallace,
Immunopathology of inflammatory bowel disease.
2014,
Pubmed
Xu,
Dysregulation of mucosal immune response in pathogenesis of inflammatory bowel disease.
2014,
Pubmed
Yarur,
Therapeutic drug monitoring in patients with inflammatory bowel disease.
2014,
Pubmed
Zakirova,
[Pharmacokinetics and clinical efficacy of histochrome in patients with acute myocardial infarction].
1997,
Pubmed
Zhang,
Inflammatory bowel disease: pathogenesis.
2014,
Pubmed
Zhou,
YAP Aggravates Inflammatory Bowel Disease by Regulating M1/M2 Macrophage Polarization and Gut Microbial Homeostasis.
2019,
Pubmed
Zhu,
Disequilibrium of M1 and M2 macrophages correlates with the development of experimental inflammatory bowel diseases.
2014,
Pubmed
